Conifer Health Solutions, a leader in business process solutions for healthcare providers, has reached an agreement to provide revenue cycle management services for LHP Hospital Group, Inc. of Plano, Texas. Under terms of the agreement, Conifer will be assisting LHP with management of Patient Access and Business Office Services at all of its hospitals. The hospitals are working with Conifer as part of their plan to standardize processes, implement best practices and create scale. He said that bringing in an established revenue cycle management company will help the facilities increase productivity, reduce risk and provide immediate best practices to the hospitals.
Conifer Health Solutions, Inc. is a wholly owned subsidiary of Tenet Healthcare Corporation (NYSE:THC). Conifer Health Solutions provides Revenue Cycle and Patient Communications services to more than 100 hospitals and health systems nationwide.
~~~~~~~~~~~~
CLNO, Cleantech Transit, Inc., CLNO.OB
Cleantech expects to finalize its initial interest in the project around July 15th and is in talks to further increase its interest in the 500 KW project in Merced County. In addition, the Company hopes to negotiate definitive terms for the previously announced larger projects. In particular Cleantech is interested in the larger 1 MW biomass gasification facilities and will provide additional details as the Company has confirmed terms on the larger projects.
“We are pleased to be making progress towards building a portfolio of green friendly assets and hopes to build off the success the 500 KW Merced Project has achieved thus far,” said Mr. Kenneth Bosket, Cleantech’s President and CEO.
Biomass, a renewable energy source, is biological material from living, or recently living organisms, such as wood, waste, (hydrogen) gas, and alcohol fuels.
Example of Successful Wood-Waste-to-Energy Applications: Wood-Fired Cogeneration Provides Reliable Off-Grid Power for Maryland Correctional Facility
A Maryland Department of Corrections facility has cut its fuel costs by 63 percent by producing its own power using a wood-chip-fired cogeneration plant.
For this facility, on the eastern shore near the town of Westover, the decision to depend on a wood-fired power plant was driven predominantly by issues of energy security. The rural area surrounding the prison is isolated from the normal energy supply infrastructure. There are no natural gas pipelines or direct road or rail links.
Since power interruptions cannot be tolerated at a prison, having a dedicated power system at this site was deemed a necessity.
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech has expanded its focus to invest directly in specific green projects that can maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Cleantech’s manufacturing clients worldwide.
Discover more about CLNO at www.cleantechtransitinc.com
~~~~~~~~~~~~
Boston Scientific Corporation (NYSE:BSX) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its 2.25 mm PROMUS(R) Everolimus-Eluting Coronary Stent System for use in vessels as small as 2.25 mm in diameter. The Company plans to immediately launch the product in the U.S.
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide.
~~~~~~~~~~~~
Power3 Medical Products, Inc. (PWRM.OB)
Power3 Medical Products, Inc., a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced PWRM management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.
Alzheimer’s is one, among the common sort of dementia, an over-all term regarding loss of memory and various other intellectual abilities serious enough to interfere with routine daily life. Alzheimer’s condition is the reason for 50 to seventy per cent of dementia cases.
Alzheimer’s disease just isn’t an everyday aspect of increasing age, although the most significant identified risk factor is increasing age, and the most of individuals with Alzheimer’s are 65 and older. Alzheimer’s is just not a illness connected with senior years. As much as five percentage of people with the actual condition have early-onset Alzheimer’s (also called younger-onset), which frequently appears when someone is in an individual’s 40s or 50s.
Alzheimer’s declines ultimately. Alzheimer’s is a progressing sickness, in which symptoms gradually worsen over a period of time. Continuing, memory loss is minor, but with late-stage Alzheimer’s, people will not be able to hold on a conversation and respond to their natural environment. Alzheimer’s disease is the 6th major cause of loss of life in the USA. Some people that have Alzheimer’s live life an average of eight years after their indications come to be noticeable to other people, but survival can range from 3 to 20 years, based on maturity and various health conditions.
Alzheimer’s disease is among the most well known form of dementia, a broad term when it comes to forgetfulness and other intellectual abilities critical enough to obstruct everyday life. Alzheimer’s diseases is the reason for 50 to seventy per cent of dementia cases.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro(R), a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Please visit Power3 Medical Products, Inc website http://www.power3medical.com
~~~~~~~~~~~~
Suntech Power Holdings Co. Ltd. (NYSE:STP), the world’s largest manufacturer of solar panels, and solarhybrid AG (ISIN:DE000A0LR456), a leading solar project developer, announced a strategic partnership for the supply of up to 190MW of solar panels to solarhybrid in 2011. Under the terms outlined in the agreement, Suntech will become solarhybrid’s key partner and will supply solar panels for the majority of solarhybrid’s German project pipeline in 2011. Five solar power plants, which solarhybrid is developing in Germany, will be equipped with 172MW of Suntech solar panels. Two additional projects that solarhybrid is currently developing in Italy (10MW) and Slovakia (6MW) will also be powered by Suntech solar panels. The strategic partnership builds on Suntech and solarhybrid’s collaboration on the 24.2 MW Finow Tower I project in Germany in 2010.
Suntech Power Holdings Co., Ltd., a solar energy company, engages in the design, development, manufacture, and marketing of photovoltaic (PV) products.
*************************************************************
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
*************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) anticipates receiving 2,000,000 shares of 144 restricted stocks from the company for 12 months of advertisement services for Cleantech Transit, Inc. (CLNO.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
